Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 5 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CAD
The 6 analysts offering 12 month price targets for Knight Therapeutics Inc have a median target of 6.75, with a high estimate of 7.50 and a low estimate of 6.10. The median estimate represents a 27.36% increase from the last price of 5.30.
High | 41.5% | 7.50 |
Med | 27.4% | 6.75 |
Low | 15.1% | 6.10 |
Earnings history & estimates in CAD
The next earnings announcement is expected on Mar 19, 2025.
Average growth rate | +66.30% |
Average growth rate | +66.36% |
More ▼
Revenue history & estimates in CAD
Average growth rate | +3.65% |
Average growth rate | +93.70% |
More ▼